MilliporeSigma, Jenner Institute partner on COVID-19 vaccine

By The Science Advisory Board staff writers

April 14, 2020 -- MilliporeSigma and the Jenner Institute have announced that they are preparing for large-scale manufacturing of the COVID-19 vaccine candidate ChAdOx1 nCoV-19.

While the vaccine is undergoing clinical trials, MilliporeSigma has evaluated an existing manufacturing platform for use with the new vaccine candidate, including critical processing steps. The normal process development would take six months to a year, but in just two months MilliporeSigma and the Jenner team have repurposed a previous platform to use for COVID-19 manufacturing.

MilliporeSigma is partnering with the Jenner Institute in the institute
MilliporeSigma is partnering with the Jenner Institute in the institute's efforts to develop a safe and effective vaccine for COVID-19. Image courtesy of MilliporeSigma.

Both companies have made investments over the last two years into the development of rapid, scalable platforms following good manufacturing practices and utilizing disposable technologies for the Jenner Institute's adenovirus platform. The initial work was developed with a rabies vaccine candidate and subsequently validated with different adenovirus constructs with the goal of accelerating future vaccine development and manufacturing.

The partnership, established in 2018, has become part of the rapid response to COVID-19 from the scientific community by accelerating large-scale manufacturing -- a critical and often time-consuming part of vaccine development.


Copyright © 2020 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here